Charts Iovance Biotherapeutics, Inc. Deutsche Boerse AG
Stocks
2LB
US4622601007
Biotechnology & Medical Research
|
Real-time Estimate
Tradegate
12:22:25 2026-09-18 EDT
|
5-day change | 1st Jan Change | ||
| 8.655 EUR | -5.10% |
|
+26.20% | +270.43% |
| 08-20 | Iovance's Growth Outlook Clouded as Amtagvi Faces Competition Hurdles, UBS Says | MT |
| 08-20 | UBS Adjusts Iovance Biotherapeutics Price Target to $7 From $4, Maintains Neutral Rating | MT |
Chart: Technical Analysis
Deutsche Boerse AGEUR
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| IOVA | Delayed | |
CBOE
| IOVA | Real-time | |
|
Tradegate
| 2LB | Real-time | |
|
London S.E.
| 0JDK | Delayed | |
|
Boerse Muenchen
| 2LB | Real-time | |
|
Deutsche Boerse AG
| 2LB | Delayed | |
|
Börse Stuttgart
| 2LB | Delayed | |
|
Borsa Italiana
| 1IOVA | End-of-day quote |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- IOVA Stock
- 2LB Stock
- Charts Iovance Biotherapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
